Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heartflow (HTFL) Cash & Equivalents (2023 - 2025)

Heartflow has reported Cash & Equivalents over the past 3 years, most recently at $44.8 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $44.8 million for Q4 2025, down 12.83% from a year ago — trailing twelve months through Dec 2025 was $44.8 million (down 12.83% YoY), and the annual figure for FY2025 was $44.8 million, down 12.83%.
  • Cash & Equivalents for Q4 2025 was $44.8 million at Heartflow, down from $291.2 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for HTFL hit a ceiling of $291.2 million in Q3 2025 and a floor of $44.8 million in Q4 2025.
  • Median Cash & Equivalents over the past 3 years was $75.4 million (2024), compared with a mean of $104.3 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 58.16% in 2024 and later surged 350.3% in 2025.
  • Heartflow's Cash & Equivalents stood at $122.8 million in 2023, then tumbled by 58.16% to $51.4 million in 2024, then fell by 12.83% to $44.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $44.8 million (Q4 2025), $291.2 million (Q3 2025), and $80.2 million (Q2 2025) per Business Quant data.